Discovery Partnerships – Who will you meet?

Successful strategies for cost efficiency and shortened time to market

Discovery Partnerships - Overview

The main challenge for the Pharma Industry today is how to fill up the product pipeline the fastest possible. It is essential to find new promising looking substances and compounds to get a good chance for early time to market with new drugs.

To ensure this many pharma companies cooperate with CROs to speed up development time and use different channels for risk sharing.

The increasing interest in outsourcing parts of the early discovery and the preclinical research creates and new promising business field and both, the pharma industry and the CROs, have a huge interest in exchanging and capitalizing in this area.


Don’t miss the chance to hear the latest first-hand case studies and:

  • Find out how to fill up your pipeline and increase innovation by outsourcing solutions in the early discovery stage
  • Enhance the lead optimisation and speed up the candidate development by outsourcing the chemical modifications to experienced CROs
  • Assess the capability of Indian and Chinese CROs to evaluate the potential for costs saving in your discovery projects

Hear 14 case studies from leading international companies:

  • Johnson & Johnson Pharmaceutical Research & Development, Belgium
  • AstraZeneca Ltd, UK
  • Les Laboratories Servier, France
  • Genmab B.V., The Netherlands
  • LEO Pharma A/S, Denmark
  • MSD France, Merck & Co. Inc., France
  • Nycomed GmbH, Germany
  • FibroGen Inc., USA
  • MerzPharmaceuticals GmbH, Germany
  • Schering-Plough Research Institute, UK
  • Orion Corporation ORION PHARMA Oyi, Finland
  • Johnson & Johnson, USA
  • Pfizer Ltd., UK
  • UCB Pharma S.A., Belgium
High-level content with excellent interaction; good place to exchange ideas
Jean-Louis Vidaluc, Research Manager, Institute de Recherche Pierre Fabre S.A.S.
Sponsor Media Partners
CCS Cell Culture Service Animated Media

[ Register Now ]